(PRNewsfoto/DePuy Synthes)
DePuy Synthes Acquires Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects (press release)
website TRS
WEST CHESTER, Pa., April 20, 2017 /PRNewswire/ -- DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
The acquisition from TRS brings exciting new technology with the potential to truly personalize health care solutions in Trauma, a priority platform for the business, and builds on DePuy Synthes' leadership in delivering ground-breaking innovation that improves patients' lives. With more than 50 strategic collaborations, the Johnson & Johnson Family of Companies is harnessing 3D printing technology to develop patient-specific healthcare solutions that can mean increased satisfaction and better...
